期刊文献+

302例呼吸内科慢性阻塞性肺疾病住院患者抗菌药物用药调查 被引量:3

Surveillance of Antibiotics Prescription for Inpatients with COPD in A Hospital
下载PDF
导出
摘要 目的了解呼吸内科慢性阻塞性肺疾病住院患者抗菌药物使用情况,促进抗菌药物的合理使用。方法回顾性调查某院呼吸内科2011—01—01,12—31出院的慢性阻塞性肺疾病住院患者病历。内容包括患者基本情况、诊断、过敏史、住院时长、用药情况、住院费用、药品费用和用药合理性评价等。结果共302例患者,主要诊断为慢性阻塞性肺病、慢性阻塞性肺病伴急性加重和慢性阻塞性肺病伴肺部感染等;氟喹诺酮类、β-内酰胺类/β-内酰胺酶抑制剂、头孢菌素类和大环内酯类等是最常用的抗菌药物;抗菌药物的使用在给药剂量和频次等方面存在某些不合理现象。结论慢性阻塞性肺疾病的抗菌药物应用基本符合指南的要求,但临床医生应能根据抗菌药物的PK/PD药代动力学特点更好地制订个体化的给药方案。 Objective To collect some information on antimicrobial prescription for patients of inpatients with chronic obstructive pulmonary disease (COPD) in a hospital, and to improve the rational application of antimicrobials. Methods: Records of inpatients discharged between Jan 1st and Dec 31st 2011 at the respiratory department who were recorded information about gender, age of patients, diagnosis, history of drug allergy, antimicrobial dosage, regimen, cost, etc, were retrospectively reviewed. The appropriateness of prescriptions was evaluated. Results: A total of 302 cases were assessed. Fluoroquinolones, beta-lactamase/enzyme inhibitor, cephalosporins and macrolides were the most used antibiotics. There were some inappropriate of drug dose, interval and solvents. Conclusion: Physicians can compliance with the guidelines to improve the management of COPD, but they should individualize the regimenin accordance with the PK/PD parameters of antibiotics.
出处 《今日药学》 CAS 2013年第12期813-815,共3页 Pharmacy Today
基金 广东省医院药学研究基金(编号:2012A11)
关键词 慢性阻塞性肺疾病 抗菌药物 临床药学 chronic obstructive pulmonary disease (COPD) antibiotics clinical pharmacy
  • 相关文献

参考文献3

二级参考文献15

  • 1谢灿茂,周宇麒.慢性阻塞性肺疾病急性加重的诊断与治疗新进展[J].中华结核和呼吸杂志,2005,28(5):346-348. 被引量:80
  • 2刘又宁,陈民钧,赵铁梅,王辉,王睿,刘庆锋,蔡柏蔷,曹彬,孙铁英,胡云建,修清玉,周新,丁星,杨岚,卓建生,唐英春,张扣兴,梁德荣,吕晓菊,李胜歧,刘勇,俞云松,魏泽庆,应可净,赵峰,陈萍,侯晓娜.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8. 被引量:786
  • 3有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:279
  • 4冉丕鑫 王辰 姚婉贞 等.我国部分地区慢性阻塞性肺疾病流行病学研究[J].中华结核和呼吸杂志,2007,.
  • 5GOLD Executive Committee[DB/OL]. Guidelines: Global Strategy for Diagnosis, Management, and Prevention of COPD,November 2006 [ 2006-11-18 ]. http://www.goldcopd.com/Guidelineitem. asp? 11 =2&12 = 1&intId =989.
  • 6Celli BR, MacNee W, Committee members. Standard for the diagnosis and treatment of patients with COPD : a summary of the ATS/ERS position paper. Eur Respir J, 2004,23:932-946.
  • 7Celli BR, Cote CG, Matin JM, et al. The body mass index,airflow obstruction, dyspnea and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med, 2004,350 : 1005-1012.
  • 8Anzueto A, Niederman MS, Pearle J, et al. Community-Acquired Pneumonia Recovery In the Elderly(CAPRIE) :Efficacy and safety of moxifloxacin versus that of levofloxacin therapy[J]. Clin Infect Dis,2006,42(1) :73 - 81
  • 9Wilson R,Jones P, Schaberg T. Antibiotic treatmment and factors influencing short and long term outcomes of acute exacerbations of chronic bronchitis[J ]. Thorax, 2006,61 : 337 - 342
  • 10Miravitlles M, Zalacain R, Murio C, et al. Speed of recovery from acute exacerbations of chronic obstructive pulmonary disease after treatment with antimicrobials. Result of a two-year study[J]. Clin Drug Invest,2003,23:439 - 450

共引文献1788

同被引文献12

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部